Hey there! Welcome!
Get updated on
stem cell
stem cell
stem cell
Top Picks

calendar
5 May, 26
dot
link
WCO-IOF-ESCEO 2026
Key sessions on diabetes and bone health in osteoporotic patients presented at the 26th World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, Prague, Czech Republic.

calendar
5 May, 26
dot
link
WCO-IOF-ESCEO 2026
Key sessions focusing on osteoporosis therapy presented at the 26th World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, Prague, Czech Republic.

calendar
6 May, 26
dot
link
Pediatrics
  • Vit C deficiency caused severe PH with RV dysfunction and high NT proBNP in 4 children.
  • Presented with musculoskeletal symptoms or cardiorespiratory failure; scurvy signs aided diagnosis.
  • Vit C therapy led to rapid recovery, complete resolution by 3 months; sildenafil alone ineffective.
  • Important to consider this diagnosis in children with restricted diets and unexplained PH.

calendar
5 May, 26
dot
link
Diabetic Med.
  • In 166 hospitalized T2DM patients on basal-bolus insulin, AKI reduced time in range (TIR) by 7.3%-points, driven by increased time above range, with no TBR change
  • Each 100 μmol/L creatinine rise lowered TIR by 7.6%-points, AKI increased in-hospital mortality ~10-fold, along with ICU referral, & doubled 30-day readmission risk
  • Hyperglycemia is also a key concern that should be addressed in these patients.

calendar
5 May, 26
dot
link
BMC Infect. Dis. 
  • Levofloxacin was effective in 82 children with refractory Mycoplasma pneumoniae pneumonia (RMPP), with rapid fever resolution (1.96 ± 1.52 days).
  • Blood counts remained stable; WBC, neutrophils, platelets unchanged (P > 0.05).
  • AST, LDH, CK‑MB, creatinine, urea decreased after treatment (P < 0.05), indicating no liver/kidney injury.
  • Mild adverse reactions; no serious events or sequelae during 12‑month follow‑up.

calendar
4 May, 26
dot
link
Heart Rhythm.
  • Atrial fibrillation (AF) increases risk of stroke and cognitive decline; in 19,533 participants, cognitive impairment occurred in 27% no AF/no stroke, 41% no AF/stroke, 31% AF/no stroke, 43% AF/stroke (p<0.0001)
  • Females with AF/no stroke had higher risk (HR 1.18), stroke predicted cognitive decline in males with AF (HR 2.33) & without AF (HR 1.65)
  • Sex-specific differences underscore tailored risk stratification.